News
Vaxart's (VXRT) shares soar 37% after positive early trial results for its oral norovirus vaccine. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback